Search alternatives:
significantly shorter » significantly higher (Expand Search), significantly lower (Expand Search), significantly greater (Expand Search)
shorter increases » showed increases (Expand Search), showed increased (Expand Search), greater increases (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
teer decrease » mean decrease (Expand Search)
Showing 141 - 160 results of 6,846 for search '(( significantly shorter increases ) OR ( significantly ((teer decrease) OR (greater decrease)) ))', query time: 0.45s Refine Results
  1. 141
    Characteristics of chronic kidney disease patients.

    Characteristics of chronic kidney disease patients. by Nguyen Thi Hai (12700147)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 142
    Comparison of alpha diversity indexes and beta diversity in CKD patients with and without <i>S</i>. <i>stercoralis</i> infection.

    Comparison of alpha diversity indexes and beta diversity in CKD patients with and without <i>S</i>. <i>stercoralis</i> infection. by Nguyen Thi Hai (12700147)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 143
    The gut microbiota composition.

    The gut microbiota composition. by Nguyen Thi Hai (12700147)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 144
    Clustering using the unweighted pair group method with arithmetic mean (UPGMA).

    Clustering using the unweighted pair group method with arithmetic mean (UPGMA). by Nguyen Thi Hai (12700147)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 145
    Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups.

    Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 146
    Factors associated with taking a COVID-19 vaccine (female only n = 124,060,468).

    Factors associated with taking a COVID-19 vaccine (female only n = 124,060,468). by Kenechukwu C. Ben-Umeh (17996326)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 147
    Factors associated with taking a booster shot (those who had a COVID-19 vaccine before, n = 182,843,937).

    Factors associated with taking a booster shot (those who had a COVID-19 vaccine before, n = 182,843,937). by Kenechukwu C. Ben-Umeh (17996326)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 148
    Comparison of male and female vaccination rates by income group.

    Comparison of male and female vaccination rates by income group. by Kenechukwu C. Ben-Umeh (17996326)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 149
    Characteristics of population by income level.

    Characteristics of population by income level. by Kenechukwu C. Ben-Umeh (17996326)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 150
    Factors associated with taking a COVID-19 vaccine (all adults n = 241,645,704).

    Factors associated with taking a COVID-19 vaccine (all adults n = 241,645,704). by Kenechukwu C. Ben-Umeh (17996326)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 151
    Factors associated with taking a COVID-19 vaccine (male only n = 117,585,236).

    Factors associated with taking a COVID-19 vaccine (male only n = 117,585,236). by Kenechukwu C. Ben-Umeh (17996326)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 152
    Areas within one-way public transit travel time thresholds to opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024.

    Areas within one-way public transit travel time thresholds to opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024. by Marcus A. Bachhuber (8339127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 153
    Distribution of one-way public transit travel times to opioid treatment programs and expanded methadone treatment access, New York City, 2024.

    Distribution of one-way public transit travel times to opioid treatment programs and expanded methadone treatment access, New York City, 2024. by Marcus A. Bachhuber (8339127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 154
    One-way public transit travel time to opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024.

    One-way public transit travel time to opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024. by Marcus A. Bachhuber (8339127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 155
    One-way public transit travel time to opioid treatment programs and expanded methadone treatment access by percentile, New York City, 2024.

    One-way public transit travel time to opioid treatment programs and expanded methadone treatment access by percentile, New York City, 2024. by Marcus A. Bachhuber (8339127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 156
    Mean difference in one-way public transit travel time between opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024.

    Mean difference in one-way public transit travel time between opioid treatment programs, expanded methadone treatment access, and other health care facilities, New York City, 2024. by Marcus A. Bachhuber (8339127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 157
    Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS), and districts of both PPHS and EPHS.

    Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS)... by Takafira Mduluza (39754)

    Published 2025
    Save to List
    Saved in:
  18. 158
    Research dataset of the study.

    Research dataset of the study. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 159
    Pairwise comparison of muscle parameters in different groups.

    Pairwise comparison of muscle parameters in different groups. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 160
    Multifidus, erector spinae, and psoas major muscle parameters and analysis of variance results.

    Multifidus, erector spinae, and psoas major muscle parameters and analysis of variance results. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: